2Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy [ J ]. J Allergy Clin Immunol, 2009, 123(1): 167-173.
3Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study [J]. Clin Exp Allergy, 2003, 33(2) : 206-210.
4Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis [J]. Evid Based Nurs, 2005, 8 (2) : 44.
5Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study [J]. Allergy, 2004, 59(1): 45-53.
6Mailing HJ. Comparison of the clinical efficacy and safety of subcutaneous and sublingual immunotherapy: methodological approaches and experimental results [ J]. Curr Opin Allergy Clin Immunol, 2004, 4(6) : 539-542.
7Rodriguez Santos O. Sublingual immunotherapy in allergic rhinitis and asthma in 2 - 5 year-old children sensitized to mites [J]. Rev Merg Mex, 2008, 55(2) : 71-75.
8Morris DL. Use of sublingual antigen in diagnosis and treatment of food allergy [ J ]. Ann Allergy, 1969, 27 ( 6 ) : 289-294.
9Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite [J]. Clin Allergy, 1986, 16(5) : 483-491.
10Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study [ J ]. AUergol Immunopathol (Madr), 1990, 18(5): 277-284.
